Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board

Climb Bio (CLYM) announced the appointments of Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its Board of Directors. Ms. Drapkin will assume the role of Audit Committee Chair, and Mr. Cumbo will assume the role of Compensation Committee Chair. Drapkin most recently served as CEO of Graphite Bio. Cumbo currently serves as President, CEO, and director of Solid Biosciences (SLDB). In connection with the new director appointments, Simon Tate will step down from the Board of Directors and Adam Rosenberg will not seek re-election at the company’s 2025 Annual Meeting of Stockholders.